Kano et al. (39) investigated the effects of corticotrophin-releasing hormone (CRH), the central driver of the HPA axis, on adrenocorticotropic hormone (ACTH) responses in relation to alexithymia in patients with irritable bowel syndrome compared to healthy controls. This evidence concerns the gene CRH and alexithymia.